Peer Review reports
From: Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors
Original Submission | ||
---|---|---|
9 Apr 2012 | Submitted | Original manuscript |
12 Apr 2012 | Author responded | Author comments - Ruth Chiquet-Ehrismann |
Resubmission - Version 2 | ||
12 Apr 2012 | Submitted | Manuscript version 2 |
12 Apr 2012 | Author responded | Author comments - Ruth Chiquet-Ehrismann |
Resubmission - Version 3 | ||
12 Apr 2012 | Submitted | Manuscript version 3 |
12 Apr 2012 | Author responded | Author comments - Ruth Chiquet-Ehrismann |
Resubmission - Version 4 | ||
12 Apr 2012 | Submitted | Manuscript version 4 |
11 Jun 2012 | Reviewed | Reviewer Report - David Guttery |
20 Jun 2012 | Reviewed | Reviewer Report - Petra Richter |
10 Aug 2012 | Author responded | Author comments - Ruth Chiquet-Ehrismann |
Resubmission - Version 5 | ||
10 Aug 2012 | Submitted | Manuscript version 5 |
Resubmission - Version 6 | ||
Submitted | Manuscript version 6 | |
Resubmission - Version 7 | ||
Submitted | Manuscript version 7 | |
Resubmission - Version 8 | ||
Submitted | Manuscript version 8 | |
Resubmission - Version 9 | ||
Submitted | Manuscript version 9 | |
15 Aug 2012 | Author responded | Author comments - Ruth Chiquet-Ehrismann |
16 Aug 2012 | Reviewed | Reviewer Report - David Guttery |
Resubmission - Version 10 | ||
15 Aug 2012 | Submitted | Manuscript version 10 |
Publishing | ||
27 Aug 2012 | Editorially accepted | |
4 Sep 2012 | Article published | 10.1186/1472-6890-12-14 |
You can find further information about peer review here.